With recent clinical breakthroughs, developers of FcRn-targeted drugs were actively seeking partnerships to advance their candidates through to clinical phases and commercialization.

The 4th Fc-Mediated Function Summit 2024 offered a prime opportunity to showcase one's expertise in antibody engineering and design, cellular assays and flow cytometry, preclinical models, PKPD assessments, and software screening, positioning participating companies as trailblazers in the rapidly evolving field.

Each package was tailored and built to align with our partners' business goals. Our agenda was crafted with scientific precision, allowing direct connection with industry professionals vital for companys' success.

Commercial collaborations were fostered with the likes of argenx, Sanofi, Abbvie, and more, ensuring the most promising prospects were actively engaged in the event and part of crucial discussions. Companies could build their wishlist of contacts, and arrangements were made to contact them in advance of the meeting to enhance their networking experience.

If you want to connect with 60+ decision-makers, establish lasting partnerships, and gain insights into the challenges faced by drug developers in 2025, we want to hear from you!